dc.contributor.author | Ersvær, Elisabeth | |
dc.contributor.author | Brenner, Annette | |
dc.contributor.author | Vetås, Kristin | |
dc.contributor.author | Reikvam, Håkon | |
dc.contributor.author | Bruserud, Øystein | |
dc.date.accessioned | 2018-02-01T15:09:49Z | |
dc.date.available | 2018-02-01T15:09:49Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | BMC Pharmacology & Toxicology 2015, 16:12 | |
dc.identifier.issn | 2050-6511 | |
dc.identifier.uri | http://hdl.handle.net/11250/2481947 | |
dc.description | - | |
dc.language.iso | eng | |
dc.rights | Navngivelse 4.0 Internasjonal | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | |
dc.title | Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.date.updated | 2015-11-09T08:04:56Z | |
dc.subject.nsi | VDP::Medisinske fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Klinisk farmakologi: 739 | |
dc.subject.nsi | VDP::Midical sciences: 700::Basic medical, dental and veterinary sciences: 710::Clinical pharmacology: 739 | |
dc.identifier.doi | 10.1186/s40360-015-0012-2 | |
dc.identifier.cristin | 1220053 | |